All guides

Patent Box vs holding IP offshore

When the UK Patent Box (10% effective corporation-tax rate on patented profits) is the right answer versus alternative IP-holding structures.

Key takeaway

When the UK Patent Box (10% effective corporation-tax rate on patented profits) is the right answer versus alternative IP-holding structures. This guide weighs Patent Box, R&D Tax Relief against your stage, funding type and timeline using verified FundingAtlas data, and explains when each is the right call.

The question

When the UK Patent Box (10% effective corporation-tax rate on patented profits) is the right answer versus alternative IP-holding structures.

Key considerations

The factors that should shape your decision before you commit operator hours to an application.

Funding stageestablished, any
Funding typetax_incentive
Funding amountPatent Box: 10% effective Corp Tax rate • R&D Tax Relief: Up to ~27p per £1 of R&D spend
EligibilityUK company subject to corporation tax; owns or exclusively licences qualifying patents; meets the Nexus / development condition; formally elects into the regime within 2 years of the end of the accounting period in which the profit arises.
TimelineElection within 2 years of period-end. First-year computations can take 2–6 months given the Nexus tracking and streaming requirements. HMRC enquiry windows apply as for any CT600 claim.
RegionSome programmes are England-only, others run across the devolved nations or are restricted to combined-authority footprints. Check each official source.

Recommended route

**Quick answer.** Patent Box gives a 10% effective UK corporation-tax rate on profits attributable to patented products, processes and licences. Offshore IP-holding structures are increasingly difficult to defend post-BEPS and OECD Pillar Two rules — and rarely cost-effective for UK trading SMEs.

**Use Patent Box if** the company is UK-resident, profitable, holds UK or EPO-granted patents, and generates material revenue from patented IP. Conservative threshold: roughly £250k+ of qualifying profit before the compliance cost is justified.

**Do not consider offshore IP holding lightly** — substance requirements, transfer-pricing scrutiny, controlled foreign company rules and the global minimum tax mean structures that worked a decade ago now fail. Most UK SMEs that explored offshore IP since 2020 have unwound it.

**Sequencing.** Most companies claim **R&D Tax Relief** during development and **elect into Patent Box** once patents are granted and generating royalty or product revenue. The two reliefs work together.

**Conservative note.** Patent Box election is irrevocable for five years — get specialist tax advice before electing, and never rely on AI-generated guidance for the streaming calculation.

Alternative routes

Where the primary recommendation is not the right fit, these are the programmes most commonly considered alongside it.

Common mistakes

  • Starting with the largest scheme rather than the highest-fit scheme.
  • Treating funding as a one-off project rather than a 24-month strategy.
  • Underestimating the documentation effort: prior trading, prior R&D, finance pack.
  • Missing the interaction between grant income and downstream R&D tax relief.
  • Engaging a contingent-fee broker before checking whether the scheme is broker-eligible.
  • Self-selecting out of a programme based on an optimistic read of eligibility.

Decision checklist

  • Confirm your business stage, region and headcount against scheme thresholds.
  • Map the next 24 months of funding need before applying to any one programme.
  • Identify the official source for each programme on your shortlist.
  • Quantify match-funding and staged-drawdown impact on cashflow.
  • Check subsidy-control / de minimis ceilings across stacked awards.
  • Model the interaction with R&D tax relief on subsidised costs.
  • Decide whether the assessment timeline fits your delivery plan.
  • Schedule the application in the calendar before committing operator hours.

Frequently asked questions

What is this decision guide about?
When the UK Patent Box (10% effective corporation-tax rate on patented profits) is the right answer versus alternative IP-holding structures.
Which funding stage does this guide cover?
Programmes referenced here target: established, any.
What types of funding are compared?
This guide considers: tax_incentive.
How much funding could I access?
Patent Box: 10% effective Corp Tax rate. R&D Tax Relief: Up to ~27p per £1 of R&D spend.
Who is eligible for the recommended routes?
UK company subject to corporation tax; owns or exclusively licences qualifying patents; meets the Nexus / development condition; formally elects into the regime within 2 years of the end of the accounting period in which the profit arises.
How long will it take to receive funding?
Election within 2 years of period-end. First-year computations can take 2–6 months given the Nexus tracking and streaming requirements. HMRC enquiry windows apply as for any CT600 claim.
Can I apply to more than one of these programmes?
Some combinations are permitted, others are restricted by subsidy-control rules or scheme-specific exclusivity clauses. Refer to the latest programme guidance before stacking applications.
Will receiving a grant affect my R&D tax relief claim?
It can. Grant-subsidised R&D expenditure is often relievable only at a reduced rate, and the interaction depends on which scheme funded which costs. FundingAtlas could not verify the interaction for every combination; confirm with a qualified adviser.
What if my situation does not match any of the recommended routes?
Use the Funding Finder to build a personalised shortlist, or request a Funding Strategy Review for a reviewer-led assessment.
Where do I find the official source for each programme?
Patent Box: https://www.gov.uk/guidance/corporation-tax-the-patent-box — R&D Tax Relief: https://www.gov.uk/guidance/corporation-tax-research-and-development-rd-relief

Next steps